Wall Street brokerages predict that Concord Medical Services Hldg Ltd (NYSE:CCM) will announce earnings of ($0.03) per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Concord Medical Services’ earnings. The company is expected to announce its next earnings report on Monday, January 1st.
On average, analysts expect that Concord Medical Services will report full year earnings of ($0.10) per share for the current fiscal year. For the next financial year, analysts forecast that the firm will post earnings of $0.01 per share. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that follow Concord Medical Services.
Separately, Zacks Investment Research upgraded DLH from a “sell” rating to a “hold” rating in a research note on Tuesday, July 9th.
CCM traded down $0.08 during trading hours on Monday, reaching $2.74. The company’s stock had a trading volume of 8,500 shares, compared to its average volume of 9,684. Concord Medical Services has a 52 week low of $1.85 and a 52 week high of $4.19. The company’s 50-day simple moving average is $2.38. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.90. The firm has a market cap of $122.29 million, a price-to-earnings ratio of -2.28 and a beta of -0.19.
A hedge fund recently raised its stake in Concord Medical Services stock. Wedbush Securities Inc. increased its stake in shares of Concord Medical Services Hldg Ltd (NYSE:CCM) by 28.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 21,432 shares of the company’s stock after purchasing an additional 4,757 shares during the quarter. Wedbush Securities Inc.’s holdings in Concord Medical Services were worth $60,000 as of its most recent filing with the SEC. 1.79% of the stock is owned by institutional investors and hedge funds.
Concord Medical Services Company Profile
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services.
Featured Article: Market Capitalization
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.